Gene · 91746
Papers2,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diverse roles of YTHDC1 in chromatin and blood cancers. | Front Genet | 2026 | 42180517 | PubTator, text mining | PubMed |
| METTL3-dependent m6A-modified circ_0026652 facilitates immune evasion of diffuse large B-cell lymphoma cells by inhibiting CD8+ T-cell responses. | J Transl Med | 2026 | 42169108 | PubTator, text mining | PubMed |
| Epitranscriptomic silencing of the ZC3H13/m6A axis orchestrates immunosuppressive microenvironment remodeling in renal cell carcinoma via CSF2-mediated MDSCs recruitment. | J Exp Clin Cancer Res | 2026 | 42163390 | PubTator, text mining | PubMed |
| An m6A-programmed cell death signature predicts prognosis and identifies STK25 as a therapeutic target in colon adenocarcinoma. | Oncol Lett | 2026 | 42077215 | PubTator, text mining | PubMed |
| Correction: YTHDC1 modulates the malignant phenotype of retinoblastoma via SQSTM1-mediated autophagy. | Sci Rep | 2026 | 42062405 | PubTator, text mining | PubMed |
| HSF1 and YTHDC1 enhance DNA repair under heat stress by promoting repair-associated gene expression. | Nucleic Acids Res | 2026 | 42055551 | PubTator, text mining | PubMed |
| YTHDC1 Promotes Triple-Negative Breast Cancer Cell Proliferation and Stemness by Regulating BACH1 mRNA Stability in an m6A-Dependent Manner. | Mol Cancer Res | 2026 | 42029122 | PubTator, text mining | PubMed |
| YTHDC1 recognizes METTL16-dependent m6A on caRNAs and coordinates cotranscriptional splicing. | Proc Natl Acad Sci U S A | 2026 | 41980091 | PubTator, text mining | PubMed |
| Reduced YTHDF2 inhibits PD-L1 expression by stabilizing m6A-containing SPOP mRNA in colorectal cancer. | Cell Death Dis | 2026 | 41872151 | PubTator, text mining | PubMed |
| A DNA-Based Binding Assay for the m6A-RNA Reader Proteins. | Chembiochem | 2026 | 41863816 | PubTator, text mining | PubMed |
| A machine learning-based epigenetic signature reveals YTHDC1 stabilizes POU5F1 to oppose tumor progression. | J Transl Med | 2026 | 41862905 | PubTator, text mining | PubMed |
| Brain neuronal CG9593/ANGPTL4 activation mediates paternally acquired motor disorders. | Sci Adv | 2026 | 41861009 | PubTator, text mining | PubMed |
| Epitranscriptomic control of telomere maintenance. | Mol Biol Rep | 2026 | 41854934 | PubTator, text mining | PubMed |
| BGN/MDK Axis in the Melanoma Tumor Microenvironment Strengthens Tumor Malignancy by Modulating Cancer Cells and Cancer-Associated Fibroblasts Crosstalk. | Adv Sci (Weinh) | 2026 | 41833003 | PubTator, text mining | PubMed |
| Differentiation Therapy in Acute Myeloid Leukemia: Advances in Phenotypic Screening and CRISPR-Based Functional Genomics. | Acta Haematol | 2026 | 41824616 | PubTator, text mining | PubMed |
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in macrophage function regulation and immunotherapy. | Front Cell Dev Biol | 2026 | 41808933 | PubTator, text mining | PubMed |
| FLEXTAG: a small and self-renewable protein labeling system for anti-fading multi-color super-resolution imaging. | Nat Commun | 2026 | 41803112 | PubTator, text mining | PubMed |
| RNA N4-acetylcytidine modification in human cancers: from molecular function to oncogenic mechanisms. | iScience | 2026 | 41797923 | PubTator, text mining | PubMed |
| m⁶A-Modified hsa_circ_0002694 facilitates OSCC progression via the METTL14/YTHDC1/miR-616-3p/c-Myc axis. | Head Face Med | 2026 | 41796335 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/91746/papers?page=2